Corticosteroids in immunocompromised ICU patients with severe COVID-19: a multicenter retrospective study.

ingentiumby ingentium

In Discovery Literature.

Publication date: Jul 26, 2025

Open Access PDF

Concepts Keywords
August COVID-19
French ICU
Immunocompromised Immunosuppression
Retrospective Nosocomial infections
Outcomes
Steroids

Semantics

Type Source Name
disease MESH COVID-19
disease MESH Immunocompromised patients
disease MESH nosocomial infections
disease IDO immunosuppression
disease MESH Infectious Diseases
drug DRUGBANK L-Citrulline
disease MESH Infections
disease MESH Inflammation
drug DRUGBANK Coenzyme M
disease MESH Acute respiratory distress syndrome
disease MESH immune diseases
disease MESH bacterial pneumonia
disease MESH pulmonary aspergillosis
drug DRUGBANK Dexamethasone
disease MESH Hospital acquired pneumonia
disease IDO immunodeficiency
disease MESH Herpes simplex
disease MESH bloodstream infections
disease MESH Sequential organ failure assessment score
disease MESH pneumonia
disease IDO replication
disease IDO immune response
disease MESH cytokine storm
disease MESH secondary infections
disease MESH opportunistic infections
disease MESH viral infections
disease MESH viral shedding
disease MESH hyperglycemia
disease MESH adrenal insufficiency
disease MESH complications
disease MESH sarcopenia
drug DRUGBANK Oxygen
drug DRUGBANK Medical air
drug DRUGBANK Hydrocortisone
drug DRUGBANK Succinic acid
drug DRUGBANK Prednisone
disease MESH T cell leukemia
disease MESH neutropenia
disease MESH Myelodysplastic syndrome Acute myeloid leukemia
disease IDO cell
disease MESH viral load

Original Article

(Visited 2 times, 1 visits today)